Diagnostics Reimbursement

News and trends on diagnostics testing, insurance coverage, and reimbursement.

A study of the detection of potential adverse drug events or interactions found that using PGx information led to better prediction of serious issues, despite no significant change overall.

HHS Secretary Azar's implementation of PAMA resulted in market-based Medicare prices that don't accurately represent the market, ACLA argues.

ACLA was critical of the report, saying it "fails to reflect market reality" and calling on Congress to intervene to prevent further cuts.

BioReference Laboratories — which is already an in-network lab with Horizon BCBS — said that the preferred lab status includes its GeneDx subsidiary.

The health insurer renewed its longstanding clinical lab services relationship with LabCorp and added Quest as an in-network provider of such services.